Table 2.
ST elevation MI | Non-ST elevation MI | Unstable angina | |||||||
UK (n = 390) | Eur (n = 2729) | MN (n = 3696) | UK (n = 376) | Eur (n = 1602) | MN (n = 4111) | UK (n = 605) | Eur (n = 2174) | MN (n = 4457) | |
Age (years)* | 64 (12) | 64 (13) | 63 (14) | 66 (12) | 67 (12) | 67 (13) | 66 (11) | 66 (12) | 66 (12) |
Men | 68% | 72% | 71% | 67% | 68% | 61% | 62% | 65% | 61% |
Participant in a clinical trial | 8% | 6% | 9% | 5% | 4% | 5% | 6% | 11% | 4% |
Cardiac catheterisation | 6% | 7.3% | 14% | 17% | 17% | 27% | 40% | 24% | 41% |
Diabetes | 11% | 20% | 24% | 11% | 20% | 29% | 14% | 21% | 29% |
Hypertension | 36% | 48% | 54% | 36% | 56% | 65% | 45% | 61% | 70% |
Hyperlipidaemia | 26% | 34% | 40% | 27% | 40% | 49% | 49% | 45% | 56% |
Current smoking | 49% | 40% | 34% | 49% | 26% | 23% | 30% | 21% | 19% |
Length of stay (days) | 6% | 10% | 8% | 6% | 10% | 8% | 5% | 9% | 7% |
*Mean (SD).
Eur, European; MN, multinational.